Reports

7498 Results (Page 157 of 300)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

Germany Wearable Injectors Market Analysis

Germany Wearable Injectors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Wearable Injectors market is growing globally due to the strong healthcare infrastructure, rise in the incidence of lifestyle disorders, an ageing population that is more susceptible to diseases, increase in the desire for minimally invasive (MI) treatment alternatives, rise in chronic diseases like diabetes, autoimmune diseases, patient preference for self-administration medications in the comfort of their homes which enhances patient convenience, improves medication adherence, technological advancements in wearable injector technology which have improved device usability, functionality, patient experience. Continuous drug delivery provided by wearable injectors like more stable drug levels, reduced fluctuations, focus on patient centric care and cost-effective solutions provided by wearable injectors. Medtronic plc, Insulet Corporation, West Pharmaceutical Services, Inc., Enable Injections, SteadyMed Therapeutics, Inc., Sensile Medical AG, CeQur SA, Ypsomed AG, Becton, Dickinson and Company and Tandem Diabetes Care, Inc. are the key global market players in wearable injectors market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Hepatitis C Drugs Market Analysis

Japan Hepatitis C drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The market will grow as a result of a number of factors, including the expansion of the pharmaceutical sector, an ageing population, growing healthcare expenditures, urbanisation, better monitoring and screening technologies, and a rise in liver cancer and cirrhosis fatalities brought on by HBV. Some of the major key players in this market are Bristol-Myers Squibb Company Gilead Sciences, Inc. Abbvie Kadmon Holdings Inc. F. Hoffmon La Roche Ltd. GlaxoSmithKline J & J Lupin Pharmaceuticals, Inc. Merck & Co., Inc. Teva Pharmaceuticals and Zydus Pharmaceuticals.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Pharmaceutical Drugs Delivery Market Analysis

Kenya Pharmaceutical Drugs Delivery market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Drugs Delivery is growing rapidly as a result of increase in prevalence of chronic diseases, desire for healthcare systems to focus more on advanced drug delivery technologies, growing emphasis on product safety, efficacy and patient-friendliness, increasing investment for healthcare infrastructure, growing geriatric population and the need for enhanced therapeutic outcomes. Johnson & Johnson, Pfizer Inc, Novartis AG, GlaxoSmithKline plc, Roche Holding AG, AstraZeneca plc, Merck & Co., Inc, Sanofi S.A. are the key market players operating globally.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Axial Spondyloarthritis (axSpA) Market Analysis

Mexico Axial Spondyloarthritis (axSpA) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. With ongoing research and development efforts, the expansion of treatment options, and increasing patient awareness, the axSpA market is expected to witness significant growth in the coming years. AbbVie Inc., Amgen Inc., Johnson & Johnson, Novartis International AG, Pfizer Inc., Eli Lilly and Company, Merck & Co., UCB S.A., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH are the global key players in axSpA market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Influenza Medications Market Analysis

Philippines influenza medications market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to factors such an increase in influenza cases and increasing research and development for drug development initiatives, the global market for anti-flu medications is anticipated to rise. As a result of technological developments that generate a significant pipeline of novel pharmaceuticals, this industry may experience growth. Sanofi S.A, Lupin Limited, Teva Pharmaceutical Industries Ltd, Shionogi & Co. Ltd, Macleods Pharmaceutical Ltd, Alvogen Pvt. Ltd, AstraZaneca Plc, BioCryst Pharmaceuticals Inc, F. Hoffman La Roche Ltd, Novartis AG, Vitaris AG. Are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Plasma Protease C1-inhibitor Market Analysis

Saudi Arabia Plasma Protease C1-inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Plasma Protease C1-inhibitor is growing due to increasing product approvals, rising research and development, increase in incidence and prevalence of hereditary angioedema (HAE), a rare genetic condition brought on by a C1-inhibitor deficit or malfunction, Increase in diagnosis of HAE, improvements in available medicines, and the launch of novel therapies. Takeda Pharmaceutical Company, CSL Behring, Pharming Group NV, Ionis pharmaceuticals, BioCryst pharmaceuticals and kalvista pharmaceuticals are the key global market players in Plasma Protease C1-inhibitor Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Cartilage Repair/Regeneration Market Analysis

South Africa Cartilage Repair/Regeneration Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The global cartilage repair market is expanding rapidly because to an ageing population, rising obesity, rising healthcare spending, and an increase in sports-related injuries. Furthermore, a surge in innovative product introductions and the growth of medical tourism, which is raising awareness about cartilage treatment modalities around the world, is fueling market growth. Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Arthrex, Stryker Corporation, Medtronic plc, Vericel Corporation, CONMED Corporation, Anika Therapeutics, Osiris Therapeutics, Misonix, BioTissue Technologies GmbH, Histogenics Corporation, RTI Surgical Holdings, Collagen Solutions Plc, Orthocell Limited are some of the global key players in Cartilage Repair/Regeneration Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Lactoferrin Market Analysis

Spain lactoferrin market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology advances that enable effective operational maintenance, efficient production, an extended product line, elegant design and packaging, and sales monitoring are key growth factors for the lactoferrin industry. The major key players in this market are Hilmar Cheese Company, Pharming Group NV, FrieslandCamina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVitria, Milei GmbH, Ferrin-tech LLC.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE Renal Cancer Drugs Market Analysis

UAE Renal Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Renal Cancer Drugs market is growing globally due to the increasing incidences of kidney diseases and renal cancer, increased demand for immunotherapies, research and development spending on new drug development, growing aging population, increasing healthcare expenditure and favorable reimbursement policies for renal cancer drugs. Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Novartis AG, Lupin, Cipla Inc, Aurobindo Pharma, Fresenius SE & Co. KGaA, Sanofi, Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Abbott are the key global market players in renal cancer drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Dengue Vaccines Market Analysis

US Dengue Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing dengue burden globally, growing awareness and government initiatives, technological advancements in vaccine development, economic burden reduction, and collaborative efforts between vaccine manufacturers, research organisations, and government agencies are driving the Dengue Vaccines market. Sanofi Pasteur, Takeda Pharmaceutical Company Limited, Butantan Institute, Biological E. Limited, Merck & Co., Bharat Biotech International Limited, Panacea Biotec Limited, GlaxoSmithKline plc, GeneOne Life Science Inc., Inviragen (a subsidiary of Takeda Pharmaceutical Company Limited) are among the global key players in Dengue Vaccines Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis

Vietnam Methicillin-resistant Staphylococcus Aureus (MRSA) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in governmental and private financing for research and development of novel anti-MRSA medications as well as their improved screening are the main drivers of the growth of the market for treating methicillin-resistant staphylococcus aureus (MRSA). Some of the major key players in this market are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Oncology/Cancer Drugs Market Analysis

Brazil oncology/cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally rising cancer rates, rising demand for cutting-edge treatments like targeted medication therapies, an increase in the geriatric population, and pervasive lifestyle behaviors like smoking, drinking, and not exercising will all have a positive impact on the market during the projected period. The major key players in this market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Transdermal Skin Patches Market Analysis

Canada Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Glutathione Market Analysis

Egypt Glutathione Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of chronic diseases, demand in the cosmetics and beauty industry, and sports nutrition and performance enhancement are key drivers of the glutathione market. Kyowa Hakko Bio Co., Shandong Jincheng Biological Pharmaceutical Co., Kohjin Life Sciences, NOW Health Group, Merck KGaA, Kaiping Genuine Biochemical Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shenzhen GSH Bio-Technology Co., Energetic Nutrition, and TCI Chemicals are the global players in the glutathione market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Ovarian Cancer Drugs Market Analysis

France ovarian cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to develop as a result of the rising number of elderly women, rise in ovarian cancer cases, ease of use of new treatments and therapies, and increase in healthcare spending. Government spending is also accelerating the market's expansion. Some of the major key players in this market are F. Hoffmann-La Roche AG, Amgen Inc., Pfizer, Inc., Clovis Oncology, AstraZeneca, Abbvie Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Alopecia Drugs (Hair Loss) Market Analysis

Indonesia alopecia drugs (hair loss) market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of alopecia, rising awareness and consciousness among individuals about their appearance, and the development of advanced treatment technologies. Johnson & Johnson, Merck & Co., GlaxoSmithKline plc, Cipla Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Histogen Inc., Aclaris Therapeutics, and Concert Pharmaceuticals are the key players in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan HER-2 Negative Breast Cancer Market Analysis

Japan HER-2 Negative Breast Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. A number of factors, such as age, obesity, alcoholism, radiation exposure history, family history of breast cancer, family history of the disease, age at first pregnancy, onset of the menstrual cycle, and tobacco use, increase the risk of developing the disease. As a result of lifestyle changes, the incidence and prevalence of breast cancer are rising quickly. All of this will drive a HER-2 Negative Breast Cancer Market.The global HER-2 Negative Breast Cancer market’s major key players are Pfizer, Novartis AG Merck & Co. Inc., GlasxoSmithKline, Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca, Lupin, Bayer AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Pharmaceutical Excipient Market Analysis

Kenya Pharmaceutical Excipient market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Excipient is growing rapidly as a result of growing Pharmaceutical Industry, Generic Drug Production driven by patent expiration and cost considerations, drug delivery systems advncements like such as controlled-release formulations, nanoparticles, and transdermal patches, requires specialized excipients to achieve the desired drug release profiles. Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Dow, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, Chemie Trade are the key global market players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Biological Safety Testing Market Analysis

Mexico Biological safety testing Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The biological safety testing market is driven by increasing demand for biologics, stringent regulatory requirements, rising incidence of infectious diseases, technological advancements, and growth in the biotechnology and pharmaceutical industries. Charles River Laboratories International, Merck KGaA, Lonza Group Ltd., Eurofins Scientific, SGS SA, WuXi AppTec, Toxikon Corporation, Avista Pharma Solutions, Nelson Laboratories, Pace Analytical Services are among the global key players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Influenza Vaccine Market Analysis

Philippines influenza vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The government's increased emphasis on and support for the influenza vaccination is one of the major factors influencing the global market. Leading market players like CSL Limited, Sanofi, and GlaxoSmithKline plc are increasing their R&D expenditures in order to enhance their production capabilities and concentrate on the introduction of new vaccines, which is what is causing the industry to continue to grow. GlaxoSmithKline plc (U.K.), Sanofi (France), AstraZeneca (U.K.), CSL Limited (Australia), BIKEN Co., Ltd. (Japan), Abbott (U.S.), Sinovac (China) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Pneumococcal Vaccines Market Analysis

Saudi Arabia Pneumococcal Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pneumococcal Vaccines Market is growing due to the increase in the number of people suffering from pneumonia across the globe, rise in demand for specific medication for treating complications associated with the disease such as breathing issues, surge in the financial support to the researchers for developing novel intervention, increase in the introduction of novel pneumococcal vaccines, growing government spending and health-awareness efforts to successfully treat disorder development in technology, surge in healthcare expenditure, growth in population and special designation from the regulatory authority and development in the protein-based vaccines for pneumonia. Sanofi, Panacea Biotec Ltd., Pfizer Inc., Glaxo smith kline, PnuVax Incorporated, SK Bioscience, Walvax Biotechnology Co., Ltd., and Beijing Minhai Biotechnology Co., Ltd. Are the key global market players operating in pneumococcal vaccines market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Cell Based Immunotherapy Market Analysis

South Africa Cell Based Immunotherapy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of cancer, advancements in cell therapy technologies, a favourable regulatory environment, growing investments and collaborations, the trend toward personalised medicine, positive clinical outcomes, and patient demand for effective and targeted treatments are driving the cell-based immunotherapy market. Novartis, Gilead Sciences, Bristol Myers Squibb, bluebird bio, Adaptimmune Therapeutics, Cellectis, and Precision Biosciences are among the leading global players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Lipid Lowering Drugs Market Analysis

Spain lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE Respiratory Drugs Market Analysis

UAE Respiratory Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Respiratory Drugs market is growing globally due to the rising elderly population, rising respiratory disease prevalence and technological developments in respiratory medications, growing demand for combination therapies due to the rising prevalence of multi-drug-resistant bacteria, and technological advancements in drug delivery devices. The chronic obstructive pulmonary disease (COPD) segment is projected to grow at the highest CAGR during the forecast period owing to the increasing prevalence of COPD across the globe. Allied Healthcare, Cardinal Health, Covidien, Drager Medical, DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, Hamilton Medical, Invacare Corporation, NSpire Health and ResMed are the key global market players in respiratory drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Depression/Major Depressive Disorders (MDD) Market Analysis

US Depression/Major Depressive Disorders (MDD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving the Depression/Major Depressive Disorders (MDD) market include rising global depression prevalence, increased awareness and understanding of mental health issues, advancements in treatment options such as new medications and therapies, rising healthcare expenditure and insurance coverage for mental health, and government initiatives aimed at improving mental healthcare access. Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bristol Myers Squibb Company, H. Lundbeck A/S, Merck & Co., Inc., Allergan plc are global key players in Depression/Major Depressive Disorders (MDD) Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up